Metraipolis › archive › dc_457ab97df602

Impact of Biologics on Comorbidities in Patients with Psoriasis or Psoriatic Arthritis — Europe PMC PMID:41007780

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41007780
DOI
10.3390/biomedicines13092219
License (as archived)
solo-consultazione
Archived
2026-11-10T00:36:56.637Z
SHA-256 of the archived text
8ade8372bd3202108201f90bb51499bf1f0f72935fcc45f0bec40bf7b8d8b635
Stable URL of this page
https://metraipolis.com/documento/dc_457ab97df602

How to cite

Impact of Biologics on Comorbidities in Patients with Psoriasis or Psoriatic Arthritis — Europe PMC PMID:41007780 — Europe PMC (en), https://europepmc.org/article/MED/41007780 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_457ab97df602 (Metraipolis archive dc_457ab97df602, sha256 8ade8372bd3202108201f90bb51499bf1f0f72935fcc45f0bec40bf7b8d8b635)
BibTeX
@misc{dc457ab97df602,
  title = {Impact of Biologics on Comorbidities in Patients with Psoriasis or Psoriatic Arthritis — Europe PMC PMID:41007780},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007780},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_457ab97df602; sha256 8ade8372bd3202108201f90bb51499bf1f0f72935fcc45f0bec40bf7b8d8b635},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007780. Agents can read the archived copy with the MCP tool read_document.